TreeWAS – Variant ID: rs3817198

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H90 Conductive and sensorineural hearing loss	0.000	0.978	0.022
H90.5 Sensorineural hearing loss, unspecified	0.000	0.979	0.021
H90.2 Conductive hearing loss, unspecified	0.000	0.979	0.021
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.980	0.020
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.981	0.019
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.982	0.018
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.983	0.017
H90-H95 Other disorders of ear	0.000	0.984	0.016
T39.1 4-Aminophenol derivatives	0.016	0.984	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.000	0.985	0.015
H95.1 Other disorders following mastoidectomy	0.000	0.985	0.015
F45.8 Other somatoform disorders	0.000	0.985	0.015
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.986	0.014
H92 Otalgia and effusion of ear	0.000	0.986	0.014
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.014	0.986	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.014	0.986	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.987	0.013
H92.0 Otalgia	0.000	0.987	0.013
H91 Other hearing loss	0.000	0.987	0.013
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.987	0.013
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.988	0.012
H94 Other disorders of ear in diseases classified elsewhere	0.000	0.988	0.012
H91.8 Other specified hearing loss	0.000	0.988	0.012
H90.3 Sensorineural hearing loss, bilateral	0.000	0.988	0.011
T39.0 Salicylates	0.011	0.989	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.000	0.989	0.011
H95.8 Other postprocedural disorders of ear and mastoid process	0.000	0.989	0.011
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.011	0.989	0.000
H92.2 Otorrhagia	0.000	0.989	0.011
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.000	0.989	0.010
H91.3 Deaf mutism, not elsewhere classified	0.000	0.989	0.011
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.010	0.990	0.000
T39.4 Antirheumatics, not elsewhere classified	0.010	0.990	0.000
T39.2 Pyrazolone derivatives	0.010	0.990	0.000
H90.0 Conductive hearing loss, bilateral	0.000	0.990	0.010
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.000	0.990	0.010
H91.0 Ototoxic hearing loss	0.000	0.990	0.009
H91.2 Sudden idiopathic hearing loss	0.000	0.991	0.009
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.000	0.991	0.009
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.000	0.991	0.009
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.991	0.009
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.000	0.991	0.009
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.000	0.991	0.009
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.000	0.991	0.009
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.000	0.991	0.009
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.000	0.991	0.009
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.000	0.991	0.009
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.009	0.991	0.000
H91.1 Presbycusis	0.000	0.991	0.009
H93 Other disorders of ear, not elsewhere classified	0.000	0.991	0.009
H92.1 Otorrhoea	0.000	0.992	0.008
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.993	0.007
H93.3 Disorders of acoustic nerve	0.000	0.993	0.007
I69 Sequelae of cerebrovascular disease	0.007	0.993	0.000
I69.3 Sequelae of cerebral infarction	0.007	0.993	0.000
H93.8 Other specified disorders of ear	0.000	0.993	0.007
H93.0 Degenerative and vascular disorders of ear	0.000	0.994	0.006
C15.5 Lower third of oesophagus	0.006	0.994	0.000
H93.2 Other abnormal auditory perceptions	0.000	0.994	0.006
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.006	0.994	0.000
H91.9 Hearing loss, unspecified	0.000	0.994	0.006
M06.9 Rheumatoid arthritis, unspecified	0.000	0.994	0.006
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.994	0.006
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.006	0.994	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.006	0.994	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.995	0.005
H93.9 Disorder of ear, unspecified	0.000	0.995	0.005
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.995	0.005
T51.0 Ethanol	0.005	0.995	0.000
F45 Somatoform disorders	0.000	0.995	0.005
M95.0 Acquired deformity of nose	0.000	0.995	0.005
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.005	0.995	0.000
N05.9 Unspecified	0.005	0.995	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.995	0.005
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.996	0.004
H93.1 Tinnitus	0.000	0.996	0.004
F45.4 Persistent somatoform pain disorder	0.000	0.996	0.004
M80 Osteoporosis with pathological fracture	0.000	0.996	0.004
F45.0 Somatisation disorder	0.000	0.996	0.004
F45.3 Somatoform autonomic dysfunction	0.000	0.996	0.004
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.996	0.004
I69.1 Sequelae of intracerebral haemorrhage	0.004	0.996	0.000
F45.1 Undifferentiated somatoform disorder	0.000	0.996	0.004
I69.0 Sequelae of subarachnoid haemorrhage	0.004	0.996	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.996	0.004
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.000	0.996	0.004
F32.2 Severe depressive episode without psychotic symptoms	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.996	0.004
F45.9 Somatoform disorder, unspecified	0.000	0.996	0.003
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.000	0.996	0.004
M80.8 Other osteoporosis with pathological fracture	0.000	0.997	0.003
F45.2 Hypochondriacal disorder	0.000	0.997	0.003
M80.5 Idiopathic osteoporosis with pathological fracture	0.000	0.997	0.003
C79.9 Secondary malignant neoplasm, unspecified site	0.003	0.997	0.000
I10 Essential (primary) hypertension	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
M80.4 Drug-induced osteoporosis with pathological fracture	0.000	0.997	0.003
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.000	0.997	0.003
M80.2 Osteoporosis of disuse with pathological fracture	0.000	0.997	0.003
M95.4 Acquired deformity of chest and rib	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.997	0.003
M95.2 Other acquired deformity of head	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
N05 Unspecified nephritic syndrome	0.003	0.997	0.000
S40 Superficial injury of shoulder and upper arm	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
M80.88 Other osteoporosis with pathological fracture (Other)	0.000	0.997	0.003
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)	0.000	0.997	0.003
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.000	0.997	0.003
M95.8 Other specified acquired deformities of musculoskeletal system	0.000	0.997	0.003
M95.5 Acquired deformity of pelvis	0.000	0.997	0.003
M95.1 Cauliflower ear	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
C67.6 Ureteric orifice	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)	0.000	0.997	0.003
S42.40 Fracture of lower end of humerus (closed)	0.000	0.997	0.003
M80.89 Other osteoporosis with pathological fracture (Site unspecified)	0.000	0.997	0.003
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)	0.000	0.997	0.003
M80.86 Other osteoporosis with pathological fracture (Lower leg)	0.000	0.997	0.003
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.997	0.003
M80.84 Other osteoporosis with pathological fracture (Hand)	0.000	0.997	0.003
M80.83 Other osteoporosis with pathological fracture (Forearm)	0.000	0.997	0.003
M80.82 Other osteoporosis with pathological fracture (Upper arm)	0.000	0.997	0.003
M80.81 Other osteoporosis with pathological fracture (Shoulder region)	0.000	0.997	0.003
M80.80 Other osteoporosis with pathological fracture (Multiple sites)	0.000	0.997	0.003
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)	0.000	0.997	0.003
M80.58 Idiopathic osteoporosis with pathological fracture (Other)	0.000	0.997	0.003
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)	0.000	0.997	0.003
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)	0.000	0.997	0.003
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.997	0.003
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)	0.000	0.997	0.003
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)	0.000	0.997	0.003
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)	0.000	0.997	0.003
M80.0 Postmenopausal osteoporosis with pathological fracture	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.000	0.997	0.003
S00.1 Contusion of eyelid and periocular area	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T51 Toxic effect of alcohol	0.003	0.997	0.000
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)	0.000	0.997	0.002
M80.28 Osteoporosis of disuse with pathological fracture (Other)	0.000	0.997	0.002
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)	0.000	0.997	0.002
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)	0.000	0.997	0.002
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)	0.000	0.997	0.002
M80.24 Osteoporosis of disuse with pathological fracture (Hand)	0.000	0.997	0.002
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)	0.000	0.997	0.002
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)	0.000	0.997	0.002
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)	0.000	0.997	0.002
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)	0.000	0.997	0.002
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)	0.000	0.997	0.002
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)	0.000	0.997	0.002
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)	0.000	0.997	0.002
M80.36 Postsurgical malabsorption osteoporosis with pathological fracture (Lower leg)	0.000	0.997	0.002
M80.35 Postsurgical malabsorption osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.997	0.002
M80.34 Postsurgical malabsorption osteoporosis with pathological fracture (Hand)	0.000	0.997	0.002
M80.33 Postsurgical malabsorption osteoporosis with pathological fracture (Forearm)	0.000	0.997	0.002
M80.32 Postsurgical malabsorption osteoporosis with pathological fracture (Upper arm)	0.000	0.997	0.002
M80.31 Postsurgical malabsorption osteoporosis with pathological fracture (Shoulder region)	0.000	0.997	0.002
M80.30 Postsurgical malabsorption osteoporosis with pathological fracture (Multiple sites)	0.000	0.997	0.002
M80.49 Drug-induced osteoporosis with pathological fracture (Site unspecified)	0.000	0.997	0.002
M80.48 Drug-induced osteoporosis with pathological fracture (Other)	0.000	0.997	0.002
M80.47 Drug-induced osteoporosis with pathological fracture (Ankle and foot)	0.000	0.997	0.002
M80.46 Drug-induced osteoporosis with pathological fracture (Lower leg)	0.000	0.997	0.002
M80.45 Drug-induced osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.997	0.002
M80.44 Drug-induced osteoporosis with pathological fracture (Hand)	0.000	0.997	0.002
M80.43 Drug-induced osteoporosis with pathological fracture (Forearm)	0.000	0.997	0.002
M80.42 Drug-induced osteoporosis with pathological fracture (Upper arm)	0.000	0.997	0.002
M80.41 Drug-induced osteoporosis with pathological fracture (Shoulder region)	0.000	0.997	0.002
M80.40 Drug-induced osteoporosis with pathological fracture (Multiple sites)	0.000	0.997	0.002
G40.8 Other epilepsy	0.003	0.997	0.000
O81.4 Vacuum extractor delivery	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
K56.5 Intestinal adhesions [bands] with obstruction	0.000	0.997	0.003
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.003	0.997	0.000
H52.1 Myopia	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.997	0.000
T36.8 Other systemic antibiotics	0.002	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
T36.6 Rifamycins	0.002	0.997	0.000
T36.5 Aminoglycosides	0.002	0.997	0.000
T36.3 Macrolides	0.002	0.997	0.000
T36.2 Chloramphenicol group	0.002	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.997	0.000
T36.0 Penicillins	0.002	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
T47.7 Emetics	0.002	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.997	0.000
T47.5 Digestants	0.002	0.997	0.000
T47.4 Other laxatives	0.002	0.997	0.000
T47.3 Saline and osmotic laxatives	0.002	0.997	0.000
T47.2 Stimulant laxatives	0.002	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
T48.5 Anti-common-cold drugs	0.002	0.997	0.000
T48.4 Expectorants	0.002	0.997	0.000
T48.3 Antitussives	0.002	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.997	0.000
T48.0 Oxytocic drugs	0.002	0.997	0.000
M95.3 Acquired deformity of neck	0.000	0.998	0.002
N05.8 Other	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
H49.1 Fourth [trochlear] nerve palsy	0.002	0.998	0.000
S40.7 Multiple superficial injuries of shoulder and upper arm	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
S40.0 Contusion of shoulder and upper arm	0.002	0.998	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
K50.1 Crohn's disease of large intestine	0.000	0.998	0.002
H49 Paralytic strabismus	0.002	0.998	0.000
O16 Unspecified maternal hypertension	0.000	0.998	0.002
R23.8 Other and unspecified skin changes	0.000	0.998	0.002
S40.8 Other superficial injuries of shoulder and upper arm	0.002	0.998	0.000
J18.0 Bronchopneumonia, unspecified	0.002	0.998	0.000
M95.96 Acquired deformity of musculoskeletal system, unspecified	0.000	0.998	0.002
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
R29.6 Tendency to fall, not elsewhere classified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.998	0.002
T40.3 Methadone	0.002	0.998	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.002
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.002
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.002
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.002
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.000	0.998	0.002
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.002
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.002
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.002
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.000	0.998	0.002
H49.8 Other paralytic strabismus	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.002	0.998	0.000
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.002
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)	0.000	0.998	0.002
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)	0.000	0.998	0.002
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)	0.000	0.998	0.002
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)	0.000	0.998	0.002
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)	0.000	0.998	0.002
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)	0.000	0.998	0.002
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)	0.000	0.998	0.002
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
T51.8 Other alcohols	0.002	0.998	0.000
T51.3 Fusel oil	0.002	0.998	0.000
T51.2 2-Propanol	0.002	0.998	0.000
T51.1 Methanol	0.002	0.998	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
H49.4 Progressive external ophthalmoplegia	0.002	0.998	0.000
H49.2 Sixth [abducent] nerve palsy	0.002	0.998	0.000
H49.0 Third [oculomotor] nerve palsy	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
M06 Other rheumatoid arthritis	0.000	0.998	0.002
B35.3 Tinea pedis	0.002	0.998	0.000
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
F25.0 Schizoaffective disorder, manic type	0.002	0.998	0.000
H49.9 Paralytic strabismus, unspecified	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.002	0.998	0.000
H18.4 Corneal degeneration	0.000	0.998	0.002
K82.2 Perforation of gallbladder	0.002	0.998	0.000
F25.1 Schizoaffective disorder, depressive type	0.002	0.998	0.000
C79 Secondary malignant neoplasm of other sites	0.002	0.998	0.000
D26.1 Corpus uteri	0.002	0.998	0.000
F25 Schizoaffective disorders	0.002	0.998	0.000
H49.3 Total (external) ophthalmoplegia	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.000	0.998	0.002
C15 Malignant neoplasm of oesophagus	0.002	0.998	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.000	0.998	0.002
M06.34 Rheumatoid nodule (Hand)	0.000	0.998	0.002
G60.0 Hereditary motor and sensory neuropathy	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
F25.9 Schizoaffective disorder, unspecified	0.002	0.998	0.000
N97.9 Female infertility, unspecified	0.000	0.998	0.002
T50.8 Diagnostic agents	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.002	0.998	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.002	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
D68.9 Coagulation defect, unspecified	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
M06.2 Rheumatoid bursitis	0.000	0.998	0.002
M06.1 Adult-onset Still's disease	0.000	0.998	0.002
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.002	0.998	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.000	0.998	0.002
C15.3 Upper third of oesophagus	0.002	0.998	0.000
H52.0 Hypermetropia	0.002	0.998	0.000
M06.3 Rheumatoid nodule	0.000	0.998	0.002
D69.3 Idiopathic thrombocytopenic purpura	0.002	0.998	0.000
F60.5 Anankastic personality disorder	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.001	0.998	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.998	0.002
M96.8 Other postprocedural musculoskeletal disorders	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
F20 Schizophrenia	0.002	0.998	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.998	0.002
N64.8 Other specified disorders of breast	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.001	0.998	0.001
F25.8 Other schizoaffective disorders	0.002	0.998	0.000
F25.2 Schizoaffective disorder, mixed type	0.002	0.998	0.000
G31.0 Circumscribed brain atrophy	0.000	0.998	0.002
K59.8 Other specified functional intestinal disorders	0.002	0.998	0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.000	0.998	0.002
B15.9 Hepatitis A without hepatic coma	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.002	0.998	0.000
C15.2 Abdominal part of oesophagus	0.002	0.998	0.000
C15.1 Thoracic part of oesophagus	0.002	0.998	0.000
I31.9 Disease of pericardium, unspecified	0.002	0.998	0.000
X59.3 Sports and athletics area	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.002	0.998	0.000
K10.8 Other specified diseases of jaws	0.002	0.998	0.000
M90.78 Fracture of bone in neoplastic disease (Other)	0.000	0.998	0.002
D32.0 Cerebral meninges	0.000	0.998	0.002
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.998	0.002
M06.0 Seronegative rheumatoid arthritis	0.000	0.998	0.002
S42.4 Fracture of lower end of humerus	0.000	0.998	0.001
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.001
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.000	0.998	0.002
M06.8 Other specified rheumatoid arthritis	0.000	0.998	0.001
O21.0 Mild hyperemesis gravidarum	0.000	0.998	0.002
D72.8 Other specified disorders of white blood cells	0.002	0.998	0.000
F20.5 Residual schizophrenia	0.002	0.998	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.998	0.002
F60.8 Other specific personality disorders	0.001	0.998	0.000
F60.4 Histrionic personality disorder	0.001	0.998	0.000
F60.2 Dissocial personality disorder	0.001	0.998	0.000
F60.1 Schizoid personality disorder	0.001	0.998	0.000
D37.4 Colon	0.002	0.998	0.000
N64.5 Other signs and symptoms in breast	0.002	0.998	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.998	0.001
M06.18 Adult-onset Still's disease (Other)	0.000	0.998	0.001
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.998	0.001
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.998	0.001
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.998	0.001
M06.14 Adult-onset Still's disease (Hand)	0.000	0.998	0.001
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.998	0.001
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.998	0.001
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.998	0.001
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.998	0.001
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.998	0.001
M06.28 Rheumatoid bursitis (Other)	0.000	0.998	0.001
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.998	0.001
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.998	0.001
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.998	0.001
M06.24 Rheumatoid bursitis (Hand)	0.000	0.998	0.001
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.998	0.001
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.998	0.001
M06.21 Rheumatoid bursitis (Shoulder region)	0.000	0.998	0.001
M06.20 Rheumatoid bursitis (Multiple sites)	0.000	0.998	0.001
M06.39 Rheumatoid nodule (Site unspecified)	0.000	0.998	0.001
M06.38 Rheumatoid nodule (Other)	0.000	0.998	0.001
M06.36 Rheumatoid nodule (Lower leg)	0.000	0.998	0.001
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.000	0.998	0.001
M06.33 Rheumatoid nodule (Forearm)	0.000	0.998	0.001
M06.31 Rheumatoid nodule (Shoulder region)	0.000	0.998	0.001
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.998	0.002
F20.8 Other schizophrenia	0.001	0.998	0.000
H52 Disorders of refraction and accommodation	0.002	0.998	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.000	0.998	0.002
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.001
S42.41 Fracture of lower end of humerus (open)	0.000	0.998	0.001
B35.6 Tinea cruris	0.001	0.998	0.000
C49.5 Connective and soft tissue of pelvis	0.000	0.998	0.001
H43.8 Other disorders of vitreous body	0.002	0.998	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.000	0.998	0.001
S02.2 Fracture of nasal bones	0.000	0.998	0.002
C15.4 Middle third of oesophagus	0.001	0.998	0.000
F20.6 Simple schizophrenia	0.001	0.998	0.000
F20.4 Postschizophrenic depression	0.001	0.998	0.000
F20.3 Undifferentiated schizophrenia	0.001	0.998	0.000
F20.2 Catatonic schizophrenia	0.001	0.998	0.000
F20.1 Hebephrenic schizophrenia	0.001	0.998	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.998	0.001
C15.0 Cervical part of oesophagus	0.001	0.998	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.001	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.001	0.998	0.001
T45.8 Other primarily systemic and haematological agents	0.001	0.998	0.001
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.001
T45.6 Fibrinolysis-affecting drugs	0.001	0.998	0.001
T45.4 Iron and its compounds	0.001	0.998	0.001
T45.3 Enzymes, not elsewhere classified	0.001	0.998	0.001
M46.46 Discitis, unspecified (Lumbar region)	0.001	0.998	0.000
C49.4 Connective and soft tissue of abdomen	0.000	0.998	0.001
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.001	0.999	0.000
M06.4 Inflammatory polyarthropathy	0.000	0.999	0.001
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.999	0.001
M06.30 Rheumatoid nodule (Multiple sites)	0.000	0.999	0.001
C69.3 Choroid	0.000	0.999	0.001
K07.3 Anomalies of tooth position	0.001	0.999	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
T45.2 Vitamins, not elsewhere classified	0.001	0.999	0.001
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.999	0.001
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.999	0.001
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.999	0.001
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.999	0.001
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.999	0.001
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.999	0.001
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.999	0.001
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.000	0.999	0.001
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.999	0.001
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.999	0.001
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.999	0.001
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.999	0.001
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.999	0.001
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.999	0.001
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.999	0.001
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.999	0.001
L53.8 Other specified erythematous conditions	0.000	0.999	0.001
M06.32 Rheumatoid nodule (Upper arm)	0.000	0.999	0.001
S02.21 Fracture of nasal bones (open)	0.000	0.999	0.001
Q50.4 Embryonic cyst of Fallopian tube	0.001	0.999	0.000
Z50.0 Cardiac rehabilitation	0.001	0.999	0.000
G40 Epilepsy	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations